Search

everythinglearnresearchcommunity

for

Search:↓

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

A woman with myotonic dystrophy had multiple skin tumors on her scalp, suggesting a genetic link.

TCDD changes skin cell growth and keratin production in mice.

Gene and cell therapies are being developed to treat rare skin conditions like epidermolysis bullosa and ichthyosis.

EGFR inhibitors can cause yellowish skin eruptions.

Removing a tumor may resolve associated skin and hair symptoms.

Recognizing macro-TSH is crucial to avoid unnecessary treatments.

Understanding patients' views on their illness can help improve their disease management.

Trichilemmal carcinoma is a rare skin cancer that requires careful diagnosis and follow-up.

Chemotherapy for leukemia led to full hair regrowth in a child with alopecia totalis.

A toddler with unusual hypothyroidism symptoms improved with levothyroxine treatment.

Multiple trichofolliculomas can look like multiple trichoepitheliomas on the face.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

A 13-year-old girl was diagnosed with juvenile lupus, showing only hair loss as a symptom.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

ECCL should be considered in patients with specific skin and eye lesions.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

The skin lesion was diagnosed as a matrical cyst with unusual features.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Topical tacrolimus effectively treated scalp lesions, reversed skin atrophy, and promoted hair growth.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Telomerase-positive cells are mainly in the bulb matrix and outer root sheath of hair follicles.

Trichogerminoma is a rare, benign skin tumor from hair cells, with a small risk of becoming cancerous.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.